NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Professor Sir Alasdair Breckenridge

Practice Area Focus

  • Health Care Policy
  • Pharmaceutical Product Development and Regulatory Strategy
  • EU Clinical Trials
  • Health Technology Assessment
  • Benefits-Risk Evaluation & Strategies
  • EU Pricing & Reimbursements
  • Bioethics


Sir Alasdair Breckenridge is former Chair of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK, the Department of Health agency responsible for regulating all medicines and medical devices. During his tenure at MHRA, Sir Alasdair served as the first Chair of the Department of Health's Emerging Science and Bioethics Advisory Committee (ESBAC), an organization responsible for providing advice to UK health departments on emerging healthcare scientific developments and their ethical, legal, social and economic implications. He was a member of the Medical Research Council, and he worked closely on several programs of the European Union, the World Health Organization and the International Union of Pharmacology, and as Chair of the Committee on Safety of Medicines. Prior to MHRA, he was Professor of Clinical Pharmacology at the University of Liverpool and a member and then Chairman of local and regional health authorities in the north-west of England, including Chairman of the North West Regional Office. Sir Alasdair is a clinical pharmacologist and after training at the Royal Postgraduate Medical School, he was appointed to the Chair of Clinical Pharmacology at the University of Liverpool. Sir Alasdair was knighted in 2004.